Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Peptic Ulcer

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    November 2022
  1. JAVIER BF, Nicolas S, Virginia C, Karina E, et al
    Low-grade duodenal eosinophilia is associated with cagA in Helicobacter pylori related dyspepsia.
    J Gastroenterol Hepatol. 2022 Nov 5. doi: 10.1111/jgh.16051.
    PubMed     Abstract available


  2. PARK SK, Kim MH, Jung JY, Oh CM, et al
    Change in smoking status and its relation to the risk of gastroduodenal ulcer in Korean men.
    J Gastroenterol Hepatol. 2022;37:2091-2097.
    PubMed     Abstract available


    October 2022
  3. SIMADIBRATA DM, Syam AF, Lee YY
    A Comparison of Efficacy and Safety of Potassium Channel Acid Blocker and Proton Pump Inhibitor in Gastric Acid-related Diseases: A Systematic Review and Meta-analysis.
    J Gastroenterol Hepatol. 2022 Oct 1. doi: 10.1111/jgh.16017.
    PubMed     Abstract available


    September 2022
  4. TAN ND, Liu XW, Liu CX, Li SB, et al
    The efficacy of keverprazan for duodenal ulcer: a phase II randomized, double-blind, parallel-controlled trial.
    J Gastroenterol Hepatol. 2022 Sep 6. doi: 10.1111/jgh.16000.
    PubMed     Abstract available


    August 2022
  5. LI K, Cheng X, Jin R, Han T, et al
    The influence of different proton pump inhibitors and potassium-competitive acid blockers on indomethacin-induced small intestinal injury.
    J Gastroenterol Hepatol. 2022 Aug 8. doi: 10.1111/jgh.15973.
    PubMed     Abstract available


  6. EUSEBI LH, Telese A, Cirota GG, Haidry R, et al
    Effect of gastro-esophageal reflux symptoms on the risk of Barrett's esophagus: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2022;37:1507-1516.
    PubMed     Abstract available


    July 2022
  7. JUNG YS, Kim S, Kim HY, Noh SJ, et al
    7-day versus 14-day tegoprazan-based triple therapy to treat Helicobacter pylori infection: Real-world evidence.
    J Gastroenterol Hepatol. 2022 Jul 11. doi: 10.1111/jgh.15939.
    PubMed     Abstract available


  8. WANG JW, Hsu PI, Lin MH, Kao JY, et al
    The efficacy of culture-guided versus empirical therapy with high-dose proton pump inhibitor as third-line treatment of Helicobacter pylori infection - A real-world clinical experience.
    J Gastroenterol Hepatol. 2022 Jul 11. doi: 10.1111/jgh.15942.
    PubMed     Abstract available


    June 2022
  9. OUYANG Y, Wang M, Xu YL, Zhu Y, et al
    Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2022 Jun 18. doi: 10.1111/jgh.15917.
    PubMed     Abstract available


    May 2022
  10. KAKIUCHI T, Okuda M, Matsuo M, Fujimoto K, et al
    Smart Gene as an effective noninvasive point-of-care test to detect Helicobacter pylori clarithromycin-resistant mutation.
    J Gastroenterol Hepatol. 2022 May 13. doi: 10.1111/jgh.15887.
    PubMed     Abstract available


  11. PARK DH, In Seo S, Lee KJ, Kim J, et al
    Long-term proton pump inhibitor use and risk of osteoporosis and hip fractures: a nationwide population-based and multicenter cohort study using a common data model.
    J Gastroenterol Hepatol. 2022 May 2. doi: 10.1111/jgh.15879.
    PubMed     Abstract available


  12. XIAO Y, Wu JCY, Lu CL, Tseng PH, et al
    Clinical practice guidelines for esophageal ambulatory reflux monitoring in Chinese adults.
    J Gastroenterol Hepatol. 2022;37:812-822.
    PubMed     Abstract available


    April 2022
  13. HUANG Y, Chen J, Ding Z, Liang X, et al
    Susceptibility testing alone will not reliably achieve high Helicobacter pylori cure rates: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2022 Apr 17. doi: 10.1111/jgh.15864.
    PubMed     Abstract available


    March 2022
  14. HOU X, Meng F, Wang J, Sha W, et al
    Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.
    J Gastroenterol Hepatol. 2022 Mar 27. doi: 10.1111/jgh.15837.
    PubMed     Abstract available


  15. KUDO Y, Kudo SE, Miyachi H, Ichimasa K, et al
    Changes in halitosis value before and after Helicobacter pylori eradication: A single-institutional prospective study.
    J Gastroenterol Hepatol. 2022 Mar 24. doi: 10.1111/jgh.15835.
    PubMed     Abstract available


  16. SCHUBERT JP, Woodman RJ, Mangoni AA, Rayner CK, et al
    Geospatial analysis of Helicobacter pylori infection in South Australia: should location influence eradication therapy?
    J Gastroenterol Hepatol. 2022 Mar 21. doi: 10.1111/jgh.15832.
    PubMed     Abstract available


  17. YANG W, Yusufu Y, Wang C
    Gastrointestinal: A rare case of upper gastrointestinal bleeding: Splenosis mimicking gastric varices.
    J Gastroenterol Hepatol. 2022 Mar 1. doi: 10.1111/jgh.15795.
    PubMed    


    February 2022
  18. KHAN R, Saha S, Gimpaya N, Bansal R, et al
    Outcomes for upper gastrointestinal bleeding during the first wave of the COVID-19 pandemic in the Toronto area.
    J Gastroenterol Hepatol. 2022 Feb 16. doi: 10.1111/jgh.15804.
    PubMed     Abstract available


  19. TERASAKI K, Ueno A, Mizuno C, Shima T, et al
    Gastrointestinal: Pembrolizumab-induced gastric ulcer occurring as an immune-related adverse event.
    J Gastroenterol Hepatol. 2022 Feb 9. doi: 10.1111/jgh.15788.
    PubMed    


    December 2021
  20. MANEERATTANAPORN M, Pittayanon R, Patcharatrakul T, Bunchorntavakul C, et al
    Thailand Guideline 2020 for Medical Management of Gastroesophageal Reflux Disease (GERD).
    J Gastroenterol Hepatol. 2021 Dec 14. doi: 10.1111/jgh.15758.
    PubMed    


  21. KOUNTOURAS J, Doulberis M, Polyzos SA, Kazakos E, et al
    Impact of Helicobacter pylori-related metabolic syndrome with hyperhomocysteinemia on extragastric pathologies.
    J Gastroenterol Hepatol. 2021 Dec 10. doi: 10.1111/jgh.15753.
    PubMed    


  22. REN S, Cai P, Liu Y, Wang T, et al
    Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2021 Dec 3. doi: 10.1111/jgh.15751.
    PubMed     Abstract available


    October 2021
  23. YONGWATANA K, Harinwan K, Chirapongsathorn S, Opuchar K, et al
    Curcuma longa Linn Versus Omeprazole in Treatment of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    J Gastroenterol Hepatol. 2021 Oct 15. doi: 10.1111/jgh.15705.
    PubMed     Abstract available


  24. BUNCHORNTAVAKUL C, Buranathawornsom A
    Randomized Clinical Trial: 7-day Vonoprazan-based versus 14-day Omeprazole-based Triple Therapy for Helicobacter pylori.
    J Gastroenterol Hepatol. 2021 Oct 7. doi: 10.1111/jgh.15700.
    PubMed     Abstract available


    August 2021
  25. UENO M, Mano T, Kayahara T, Mizuno M, et al
    Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding: It's time to step forward.
    J Gastroenterol Hepatol. 2021 Aug 8. doi: 10.1111/jgh.15652.
    PubMed    


  26. SIKAVI DR, Cai JX, Carroll TL, Chan WW, et al
    Prevalence and clinical significance of esophageal motility disorders in patients with laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2021;36:2076-2082.
    PubMed     Abstract available


    July 2021
  27. CHO JH, Jin SY, Park S
    Scoring model for discriminating gastric cancer risk in patients with negative serum pepsinogen and anti-Helicobacter pylori antibody results.
    J Gastroenterol Hepatol. 2021 Jul 19. doi: 10.1111/jgh.15630.
    PubMed     Abstract available


  28. CHEN Y, Xu C, Xu H, Chen W, et al
    Persistent Helicobacter pylori infection for more than 3 years leads to elevated serum homocysteine concentration: a retrospective cohort study based on a healthy Chinese population.
    J Gastroenterol Hepatol. 2021 Jul 1. doi: 10.1111/jgh.15603.
    PubMed     Abstract available


  29. SUNG JJ
    Clopidogrel is no better or worse than aspirin when combined with proton pump inhibitors in the prevention of major adverse event. Is the jury out?
    J Gastroenterol Hepatol. 2021;36:1733-1734.
    PubMed    


    June 2021
  30. HUSSEIN M, Alzoubaidi D, O'Donnell M, de la Serna A, et al
    Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes.
    J Gastroenterol Hepatol. 2021 Jun 15. doi: 10.1111/jgh.15579.
    PubMed     Abstract available


  31. GINGOLD-BELFER R, Niv Y, Schmilovitz-Weiss H, Levi Z, et al
    Susceptibility-Guided vs Empirical Treatment for Helicobacter pylori infection: a Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2021 Jun 11. doi: 10.1111/jgh.15575.
    PubMed     Abstract available


  32. HORII T, Suzuki S, Takano C, Shibuya H, et al
    Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2021 Jun 9. doi: 10.1111/jgh.15572.
    PubMed     Abstract available


    May 2021
  33. JEON HJ, Moon HS, Kwon IS, Kang SH, et al
    Which scoring system should be used for non-variceal upper gastrointestinal bleeding? Old or New?
    J Gastroenterol Hepatol. 2021 May 24. doi: 10.1111/jgh.15555.
    PubMed     Abstract available


    March 2021
  34. QIAO C, Li Y, Liu J, Ji C, et al
    Clarithromycin versus furazolidone for naive Helicobacter pylori infected patients in a high clarithromycin resistance area.
    J Gastroenterol Hepatol. 2021 Mar 10. doi: 10.1111/jgh.15468.
    PubMed     Abstract available


  35. KODAMA M, Okimoto T, Mizukami K, Hirashita Y, et al
    Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: a long-term prospective follow-up study.
    J Gastroenterol Hepatol. 2021 Mar 3. doi: 10.1111/jgh.15477.
    PubMed     Abstract available


    February 2021
  36. AKADA J, Tshibangu-Kabamba E, Tuan VP, Kurogi S, et al
    Serum Helicobacter pylori antibody reactivity in seven Asian countries using an automated latex aggregation turbidity assay.
    J Gastroenterol Hepatol. 2021 Feb 20. doi: 10.1111/jgh.15467.
    PubMed     Abstract available


    January 2021
  37. KATO M, Hayashi Y, Nishida T, Oshita M, et al
    Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis.
    J Gastroenterol Hepatol. 2021 Jan 5. doi: 10.1111/jgh.15396.
    PubMed     Abstract available


  38. NIIKURA R, Aoki T, Kojima T, Kawahara T, et al
    Natural history of upper and lower gastrointestinal bleeding in hemodialysis patients: A dual-center long-term cohort study.
    J Gastroenterol Hepatol. 2021;36:112-117.
    PubMed     Abstract available


    November 2020
  39. YANG SC, Wu CK, Tai WC, Liang CM, et al
    Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding.
    J Gastroenterol Hepatol. 2020 Nov 28. doi: 10.1111/jgh.15360.
    PubMed     Abstract available


  40. SCHUBERT JP, Gehlert J, Rayner CK, Roberts-Thomson IC, et al
    Antibiotic Resistance of Helicobacter pylori in Australia and New Zealand: A Systematic Review and Meta-analysis.
    J Gastroenterol Hepatol. 2020 Nov 20. doi: 10.1111/jgh.15352.
    PubMed     Abstract available


    October 2020
  41. GINGOLD-BELFER R, Niv Y, Levi Z, Boltin D, et al
    Rifabutin triple therapy for first-line and rescue treatment of Helicobacter pylori infection: a systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2020 Oct 10. doi: 10.1111/jgh.15294.
    PubMed     Abstract available


  42. TANG C, Zhu Y, Yang X, Xu B, et al
    Upper gastrointestinal mucosal injury associated with ticagrelor plus aspirin, ticagrelor alone, or aspirin alone at 1-year after coronary artery bypass grafting.
    J Gastroenterol Hepatol. 2020;35:1720-1730.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: